Ann: Atomo & Access Bio sign deal for rapid antigen test, page-43

I think some holders limit themselves to thinking we need to scale up manufacturing capacity to achieve greater results.

What I see is a young growing company with only 400m SOI and the ability to easily raise millions of dollars to acquire and diversify the business and create other revenue opportunities with as little as another 100m SOI.

If we think outside the box the possibilities are endless.

This company IMO will not be doing exactly as it is in 12 months time - I suspect it will be bigger and better.

As some holders said - set & forget

DYOR